| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| GTO ID | GTC1093 |
| Trial ID | CTRI/2023/11/059795 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BCMA CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Not Recruiting |
| Title | Evaluation of the safety and efficacy of anti-BCMA CAR-T product (cell therapy) in Patients with Multiple Myeloma. |
| Year | 2023 |
| Country | India |
| Company sponsor | Aurigene Oncology Limited |
| Cohort 1 | |||||
|
|||||